RxDoctor Payments Data

Jennifer Marco

Psychiatric/Mental Health · Syracuse, NYNPI 1245970219

Payments from drug & device makers

$4,131in general payments, 2019–2025

Across 176 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$446
  • Indivior Inc.$374
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$372
  • Teva Pharmaceuticals USA, Inc.$252
  • Alkermes, Inc.$242
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$4,131100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,131 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole11$32,848
VraylarCariprazine Hcl17$23,536
NuedextaDextromethorphan Hbr/Quinidine11$16,653
Clozapine OdtClozapine12$2,977
Perphenazine13$1,620
Chlorpromazine Hcl18$1,495
Clozapine25$1,347
Atomoxetine Hcl19$745
Quetiapine Fumarate52$722
Prazosin Hcl64$603
Duloxetine Hcl48$575
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine33$541
Bupropion XlBupropion Hcl49$529
Buspirone Hcl55$488
Aripiprazole35$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$446$32,84811 claims
AbbVieVraylar$1,427$23,53617 claims
Avanir Pharmaceuticals, Inc.Nuedexta$43$16,65311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →